LaPlume Joseph W's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Aug 12, 2024
- Accession no.
- 0001127602-24-022003
- Filed
- Aug 12, 2024
- Trade date
- Aug 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $354.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaPlume Joseph WCIK 0001767215 | Officer (EVP, Corp Strategy & Develop) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | Common Stock | SSaleDisposed | −1,780 | $199.36 | −$354,860.8 | 22,521 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.